Adverse reactions of low osmolality contrast media during cardiac angiography: a prospective randomized multicenter study.

A multicenter study was performed to determine the incidence of adverse reactions to two contrast media with similar low osmolality during cardiac angiography. The study was of a randomized double-blind design comparing ioxaglate (an ionic dimer) and iopamidol (a nonionic compound) and included 500 patients; 250 patients received ioxaglate and 250 iopamidol. There were 58 adverse reactions attributed to the contrast media in the ioxaglate group and 29 in the iopamidol group (p less than 0.001). Chest pain occurred in 11 patients in the ioxaglate group compared with 5 in the iopamidol group (p = 0.123). Nausea or vomiting was present in 20 and 2 patients, respectively (p less than 0.0003). Allergic adverse reactions, such as bronchospasm, urticaria and itching, occurred in 15 of the ioxaglate group and only 1 of the patients receiving iopamidol (p less than 0.0007). Fifty-two patients in the ioxaglate group had a known allergic history (not to contrast medium) or asthma, whereas 77 receiving iopamidol had a similar history. Seven of the 52 ioxaglate-treated patients developed an allergic adverse reaction compared with none of the 77 in the iopamidol group (p = 0.001). Of 41 patients receiving ioxaglate who were premedicated with diphenhydramine, 4 had an allergic adverse event. In the iopamidol group 45 patients received similar premedication and none had an allergic adverse reaction (p less than 0.03). Thus, this multicenter study shows that adverse reactions occur more often with ioxaglate than with iopamidol and that patients with an allergic history have a greater risk with ioxaglate therapy compared with iopamidol.

Radiation safety in the cardiac catheterization laboratory.

Over the years, permissible radiation exposure of operators working with x-ray equipment has become progressively reduced. The number of cardiac catheterizations and related interventional procedures has increased and the procedures have become more prolonged. The patient receives relatively infrequent primary radiation while the operator receives frequent but mainly secondary radiation. The operator uses protective barriers, correct positioning of the patient and careful techniques to reduce radiation exposure. The effects of radiation are cumulative and permanent. They may be stochastic or nonstochastic, and somatic and/or genetic, and onset may be delayed for many years. To minimize exposure of patient and operator, cardiologists need a better understanding of radiation physics and of cardiac x-ray equipment. Technical breakthroughs such as digital imaging, pulse fluoroscopy, reduction of frame rates from 60 or 30 frames/s to 15 frames/s, and progression to the filmless laboratory will substantially reduce radiation. This review discusses current cardiac x-ray equipment, possible future developments, radiation, and techniques for reducing radiation and improving safety in the cardiac catheterization laboratory.

The posterior left atrial echocardiogram of mitral regurgitation.

The motion of the posterior wall of the normal left atrium has not been studied systematically. The superoposterior portion of the left atrium is adynamic throughout the cardiac cycle, whereas the inferoposterior portion is displaced posteriorly with left atrial filling during ventricular systole. In the present study, the left atrial diameter (LAD), the left atrial systolic motion (LASM) and the left atrial systolic velocity (LASV), were determined in the following groups of patients: 34 normals; eight patients with either coronary artery disease or aortic stenosis; six patients with aortic insufficiency; and three patients with ventricular septal defect. The results obtained were compared to 15 patients with angiographically documented mitral regurgitation. In the last group, the LAD (4.2 +/- .19 cm) and LASV (12.3 +/- 1.23 cm) and LASM (1.2 +/- 0.4 cm) were significantly greater reflecting the early accentuated filling of the left atrium induced by mitral regurgitation. As well, the product of these three parameters was greater in the mitral regurgitation group (63.2 +/- 7.34 cm3/sec) than in the other groups and patients with mild to moderate regurgitation had a significantly lower value than those with moderate to severe regurgitation (45.7 +/- 4.1 vs 78.5 +/- 10.9, P less than 0.02). The left atrial echocardiogram, therefore, is an aid in the diagnosis of mitral regurgitation and provides a rough index of the severity of the lesion.

How valid are utilization review tools in assessing appropriate use of acute care beds?

BACKGROUND: Despite their widespread acceptance, utilization review tools, which were designed to assess the appropriateness of care in acute care hospitals, have not been well validated in Canada. The aim of this study was to assess the validity of 3 such tools--ISD (Intensity of service, Severity of illness, Discharge screens), AEP (Appropriateness Evaluation Protocol) and MCAP (Managed Care Appropriateness Protocol)--as determined by their agreement with the clinical judgement of a panel of experts. METHODS: The cases of 75 patients admitted to an acute cardiology service were reviewed retrospectively. The criteria of each utilization review tool were applied by trained reviewers to each day the patients spent in hospital. An abstract of each case prepared in a day-by-day format was evaluated independently by 3 cardiologists, using clinical judgement to decide the appropriateness of each day spent in hospital. RESULTS: The panel considered 92% of the admissions and 67% of the subsequent hospital days to be appropriate. The ISD underestimated the appropriateness rates of admission and subsequent days; the AEP and MCAP overestimated the appropriateness rate of subsequent days in hospital. The kappa statistic of overall agreement between tool and panel was 0.45 for ISD, 0.24 for MCAP and 0.25 for AEP, indicating poor to fair validity of the tools. INTERPRETATION: Published validation studies had average kappa values of 0.32-0.44 (i.e., poor to fair) for admission days and for subsequent days in hospital for the 3 tools. The tools have only a low level of validity when compared with a panel of experts, which raises serious doubts about their usefulness for utilization review.

Autoimmune myocarditis: a clinical entity.

In a case of myocarditis electron microscopic and immunoflourescent studies of a transmural myocardial biopsy specimen indicated an autoimmune process. Extensive inflammatory cell infiltration, immunoglobulin and complement deposition along the sarcolemma and in the interstitium, and capillary endothelial injury were found. After a short course of immunosuppressive therapy the inflammatory process was replaced by collagenous scarring and lymphocytic depletion; the blood vessels were then normal. Earlier therapy in such cases may be lifesaving.

Mitral stenosis obscuring the diagnosis of plexogenic pulmonary arteriopathy and familial pulmonary hypertension.

A patient who died after surgery for critical mitral stenosis was found to have underlying unrecognised plexogenic pulmonary arteriopathy and familial pulmonary hypertension. The importance of recognising familial pulmonary hypertension is discussed, together with the contribution of genetic and other risk factors to plexogenic pulmonary arteriopathy.

Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in humans.

BACKGROUND: Pulmonary endothelium has metabolic functions including the conversion of angiotensin I to angiotensin II by angiotensin-converting ectoenzyme (ACE). In this study, we have validated an indicator-dilution technique that provides estimations of dynamically perfused capillary surface area (DPCSA) in humans, and we have characterized pulmonary endothelial ACE in vivo. METHODS AND RESULTS: In 12 adults, single-pass transpulmonary (one or both lungs) hydrolysis of the specific ACE substrate 3H-benzoyl-Phe-Ala-Pro (3H-BPAP) was measured and expressed as % metabolism (%M) and v=-ln(1-M). We also calculated Amax/Km, an index of DPCSA. %M (70.1+/-3.2 vs 67.9+/-3.1) and v (1.29+/-0.14 vs 1. 20+/-0.12) were similar in both lungs and the right lung, respectively, whereas Amax/Km//body surface area decreased from 2460+/-193 to 1318+/-115 mL/min per square meter. CONCLUSIONS: Pulmonary endothelial ACE activity can be assessed in humans at the bedside by means of indicator-dilution techniques. Our data suggest homogeneous pulmonary capillary ACE concentrations and capillary transit times (tc) in both human lungs, and similar tc within the normal range of cardiac index. Amax/Km in the right lung is 54% of total Amax/Km in both lungs, suggesting that Amax/Km is a reliable and quantifiable index of DPCSA in humans.